Actively Recruiting
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Led by Forte Biosciences, Inc. · Updated on 2025-11-20
64
Participants Needed
6
Research Sites
92 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A Randomized, Double-Blind, Placebo Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Non-Segmental Vitiligo.
CONDITIONS
Official Title
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females aged 18 to 75 years at time of Screening
- Confirmed diagnosis of non-segmental vitiligo at Screening and Baseline visits as assessed by the investigator
- Stable regimen of concomitant medications (no new drugs or dosage changes within 7 days or 5 half-lives prior to Day 1)
- Willingness to maintain stable medication regimen during the study
- Additional inclusion criteria as determined by the study center
You will not qualify if you...
- Active forms of other hypopigmentation disorders such as Vogt-Koyanagi-Harada disease, melanoma-induced hypopigmentation, post-inflammatory hypopigmentation, and others
- Active inflammatory skin diseases or skin conditions that would interfere with vitiligo evaluation or treatment response, including morphea, discoid lupus, leprosy, syphilis, psoriasis, seborrheic dermatitis
- More than approximately 33% leukotrichia (hair depigmentation) in facial vitiligo areas as assessed at screening
- Additional exclusion criteria as determined by the study center
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Skin & Cancer Foundation Australia - The Skin Hospital
Darlinghurst, New South Wales, Australia, 2010
Actively Recruiting
2
Novatrials
Kotara, New South Wales, Australia, 2289
Actively Recruiting
3
Cornerstone Dermatology
Coorparoo, Queensland, Australia, 4151
Actively Recruiting
4
Optimal Clinical Trials North
Auckland, Auckland, New Zealand, 0632
Actively Recruiting
5
Optimal Clinical Trials Central
Auckland, Auckland, New Zealand, 1010
Actively Recruiting
6
Momentum Pukehoke
Auckland, Auckland, New Zealand, 2120
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here